Acrivon Therapeutics
ACRV
#7985
Rank
โ‚น16.91 B
Marketcap
โ‚น543.24
Share price
-0.92%
Change (1 day)
79.56%
Change (1 year)

Revenue for Acrivon Therapeutics (ACRV)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acrivon Therapeutics from 2022 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A